HK1208354A1 - 組合物 - Google Patents

組合物

Info

Publication number: HK1208354A1
Authority: HK; Hong Kong
Prior art keywords: compositions
Prior art date: 2012-05-01

Application number

HK15109009.3A

Other languages

English (en)

Inventor

Markus Mandler

Petra Gruber

Frank Mattner

Walter Schmidt

Original Assignee

Affiris Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-05-01

Filing date

2015-09-15

Publication date

2016-03-04

2015-09-15 Application filed by Affiris Ag filed Critical Affiris Ag

2016-03-04 Publication of HK1208354A1 publication Critical patent/HK1208354A1/zh

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0007—Nervous system antigens; Prions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0003—Invertebrate antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/34—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Corynebacterium (G)
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Organic Chemistry (AREA)
Mycology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Microbiology (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Gastroenterology & Hepatology (AREA)
Tropical Medicine & Parasitology (AREA)
Toxicology (AREA)
Zoology (AREA)
Hospice & Palliative Care (AREA)
Psychology (AREA)
Psychiatry (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)

HK15109009.3A 2012-05-01 2015-09-15 組合物 HK1208354A1 (zh)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP12166315.7A EP2659907A1 (en)	2012-05-01	2012-05-01	Compositions
PCT/EP2013/059025 WO2013164355A1 (en)	2012-05-01	2013-04-30	Compositions

Publications (1)

Publication Number	Publication Date
HK1208354A1 true HK1208354A1 (zh)	2016-03-04

Family

ID=48468232

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HK15109009.3A HK1208354A1 (zh)	2012-05-01	2015-09-15	組合物

Country Status (9)

Country	Link
US (2)	US20150093431A1 (zh)
EP (2)	EP2659907A1 (zh)
JP (1)	JP2015520739A (zh)
CN (1)	CN104427996A (zh)
AR (1)	AR090917A1 (zh)
AU (1)	AU2013255860A1 (zh)
CA (1)	CA2872138A1 (zh)
HK (1)	HK1208354A1 (zh)
WO (1)	WO2013164355A1 (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20170095573A1 (en) *	2014-06-02	2017-04-06	Baylor Research Institute	Methods and compositions for treating allergy and inflammatory diseases
US20190091306A1 (en) *	2015-11-03	2019-03-28	Affiris Ag	Method for vaccination against a self-antigen in a human patient
EA201991720A1 (ru)	2017-02-17	2020-01-20	Бристол-Маерс Сквибб Компани	Антитела к альфа-синуклеину и их применения
CN111094323B (zh)	2017-04-19	2024-02-06	葛兰素史密丝克莱恩生物有限公司	修饰的巨细胞病毒蛋白和稳定的复合物
MX2021004273A (es)	2018-10-17	2021-12-10	Glaxosmithkline Biologicals Sa	Proteinas de citomegalovirus modificadas y complejos estabilizados.
WO2020120569A2 (en)	2018-12-12	2020-06-18	Glaxosmithkline Biologicals Sa	Modified carrier proteins for o-linked glycosylation
WO2023152260A1 (en) *	2022-02-09	2023-08-17	Ac Immune Sa	Anti-alpha-synuclein therapeutic vaccines
CN117100852A (zh) *	2023-10-24	2023-11-24	江苏瑞科生物技术股份有限公司	复合佐剂及其制备方法和应用

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0114787B1 (de)	1983-01-25	1991-09-25	Ciba-Geigy Ag	Neue Peptidderivate
GB8815795D0 (en)	1988-07-02	1988-08-10	Bkl Extrusions Ltd	Glazing bead
NZ230747A (en)	1988-09-30	1992-05-26	Bror Morein	Immunomodulating matrix comprising a complex of at least one lipid and at least one saponin; certain glycosylated triterpenoid saponins derived from quillaja saponaria molina
DE69327599T2 (de) *	1992-06-25	2000-08-10	Smithkline Beecham Biolog	Adjuvantien enthaltende Impfstoffzusammensetzung
ATE204762T1 (de)	1993-03-23	2001-09-15	Smithkline Beecham Biolog	3-0-deazylierte monophosphoryl lipid a enthaltende impfstoff-zusammensetzungen
GB9326253D0 (en)	1993-12-23	1994-02-23	Smithkline Beecham Biolog	Vaccines
AUPM873294A0 (en)	1994-10-12	1994-11-03	Csl Limited	Saponin preparations and use thereof in iscoms
GB9513261D0 (en)	1995-06-29	1995-09-06	Smithkline Beecham Biolog	Vaccines
AUPO517897A0 (en)	1997-02-19	1997-04-11	Csl Limited	Chelating immunostimulating complexes
GB9712347D0 (en)	1997-06-14	1997-08-13	Smithkline Beecham Biolog	Vaccine
WO1999011241A1 (en)	1997-09-05	1999-03-11	Smithkline Beecham Biologicals S.A.	Oil in water emulsions containing saponins
US6303114B1 (en)	1998-03-05	2001-10-16	The Medical College Of Ohio	IL-12 enhancement of immune responses to T-independent antigens
TR200002930T2 (tr)	1998-04-09	2000-12-21	Smithkline Beecham Biologicals S.A.	Kolaylaştırıcı kompozisyonlar
CZ301212B6 (cs) *	1998-10-16	2009-12-09	Smithkline Beecham Biologicals S. A.	Vakcinacní prostredek
AUPP807399A0 (en)	1999-01-08	1999-02-04	Csl Limited	Improved immunogenic lhrh composition and methods relating thereto
US7776343B1 (en)	1999-02-17	2010-08-17	Csl Limited	Immunogenic complexes and methods relating thereto
CN1399539A (zh)	1999-09-24	2003-02-26	史密丝克莱恩比彻姆生物有限公司	含有聚氧乙烯烷基醚或聚氧乙烯烷基酯以及至少一种非离子表面活性剂的佐剂
EP1221971A2 (en)	1999-09-24	2002-07-17	SmithKline Beecham Biologics SA	Use of the combination of polyoxyethylene sorbitan ester and octoxynol as adjuvant and its use in vaccines
CA2466841A1 (en)	2001-11-21	2003-06-05	New York University	Synthetic immunogenic but non-deposit-forming polypeptides and peptides homologous to amyloid .beta., prion protein, amylin, .alpha.-synuclein, or polyglutamine repeats for induction of an immune response thereto
US8697082B2 (en)	2002-11-01	2014-04-15	Neotope Biosciences Limited	Prevention and treatment of synucleinopathic and amyloidogenic disease
TW200509968A (en)	2002-11-01	2005-03-16	Elan Pharm Inc	Prevention and treatment of synucleinopathic disease
CA2526900C (en)	2003-05-19	2015-11-24	Elan Pharmaceuticals, Inc.	Truncated fragments of alpha-synuclein in lewy body disease
US7358331B2 (en)	2003-05-19	2008-04-15	Elan Pharmaceuticals, Inc.	Truncated fragments of alpha-synuclein in Lewy body disease
JPWO2004113535A1 (ja)	2003-06-22	2007-09-20	早出　広司	凝集抑制作用を有するシヌクレイン変異体
EP1776105A2 (en)	2004-07-18	2007-04-25	Coley Pharmaceutical Group, Ltd	Methods and compositions for inducing innate immune responses
JP2008506789A (ja)	2004-07-18	2008-03-06	シーエスエル、リミテッド	インターフェロン−ガンマ応答強化を誘発するための免疫刺激複合体及びオリゴヌクレオチド処方物
TWI382019B (zh)	2005-08-19	2013-01-11	Array Biopharma Inc	作為類鐸受體（ｔｏｌｌ-ｌｉｋｅｒｅｃｅｐｔｏｒ）調節劑之胺基二氮雜呯
WO2008005555A1 (en)	2006-07-07	2008-01-10	Gilead Sciences, Inc.	Modulators of toll-like receptor 7
PE20091236A1 (es)	2007-11-22	2009-09-16	Astrazeneca Ab	Derivados de pirimidina como immunomoduladores de tlr7
AT506535B1 (de) *	2008-02-22	2010-04-15	Affiris Forschungs & Entwicklungs Gmbh	Vaccine enthaltend alpha-synuclein-mimotope auf basis von peptiden
WO2009111337A1 (en)	2008-03-03	2009-09-11	Irm Llc	Compounds and compositions as tlr activity modulators
ES2436540T3 (es)	2008-03-24	2014-01-02	4Sc Discovery Gmbh	Nuevas imidazoquinolinas sustituidas
DK2313111T3 (da)	2008-08-01	2013-12-02	Ventirx Pharmaceuticals Inc	Toll-lignende receptoragonistformuleringer og anvendelse deraf
US8409584B2 (en) *	2009-05-05	2013-04-02	New York University	Immunotherapy targeting of the shared abnormal conformational state of amyloidogenic peptides/proteins
AT508638B1 (de)	2009-08-21	2011-08-15	Affiris Ag	Verwendung von peptiden und polypeptiden zur behandlung und/oder prävention von synukleinopathien

2012
- 2012-05-01 EP EP12166315.7A patent/EP2659907A1/en not_active Withdrawn
2013
- 2013-04-30 EP EP13723699.8A patent/EP2844281A1/en not_active Withdrawn
- 2013-04-30 US US14/398,204 patent/US20150093431A1/en not_active Abandoned
- 2013-04-30 CN CN201380033810.0A patent/CN104427996A/zh active Pending
- 2013-04-30 WO PCT/EP2013/059025 patent/WO2013164355A1/en active Application Filing
- 2013-04-30 CA CA2872138A patent/CA2872138A1/en not_active Abandoned
- 2013-04-30 JP JP2015509424A patent/JP2015520739A/ja active Pending
- 2013-04-30 AU AU2013255860A patent/AU2013255860A1/en not_active Abandoned
- 2013-05-02 AR ARP130101498A patent/AR090917A1/es unknown
2015
- 2015-07-13 US US14/797,904 patent/US20150306194A1/en not_active Abandoned
- 2015-09-15 HK HK15109009.3A patent/HK1208354A1/zh unknown

Also Published As

Publication number	Publication date
CN104427996A (zh)	2015-03-18
AR090917A1 (es)	2014-12-17
EP2659907A1 (en)	2013-11-06
US20150093431A1 (en)	2015-04-02
WO2013164355A1 (en)	2013-11-07
EP2844281A1 (en)	2015-03-11
CA2872138A1 (en)	2013-11-07
AU2013255860A1 (en)	2014-12-11
US20150306194A1 (en)	2015-10-29
JP2015520739A (ja)	2015-07-23

Publication	Publication Date	Title
HK1215165A1 (zh)	2016-08-19	組合物
GB201200707D0 (en)	2012-02-29	Composition
HK1210019A1 (zh)	2016-04-15	殼聚糖衍生組合物
HK1208354A1 (zh)	2016-03-04	組合物
EP2878295A4 (en)	2015-12-23	COMPOSITION
ZA201503157B (en)	2016-01-27	Compositions
GB201210800D0 (en)	2012-08-01	Compositions
GB201209244D0 (en)	2012-07-04	Compositions
GB201201287D0 (en)	2012-03-07	Compositions
EP2837670A4 (en)	2016-01-13	COMPOSITION CONTAINING FLUOROBIPHENYL
EP2910537A4 (en)	2016-06-29	AGENT COMPOSITION GENERATING GAS
EP2910538A4 (en)	2016-06-29	AGENT COMPOSITION GENERATING GAS
ZA201503062B (en)	2016-01-27	Compositions
GB201220068D0 (en)	2012-12-19	Compositions
ZA201502542B (en)	2016-11-30	Compositions
ZA201406753B (en)	2015-12-23	Long acting compositions
GB201219980D0 (en)	2012-12-19	Compositions
GB201219973D0 (en)	2012-12-19	Compositions
GB201219962D0 (en)	2012-12-19	Compositions
TWI561248B (en)	2016-12-11	Peracid-generating compositions
EP2926813A4 (en)	2016-05-25	METFORMIN-Orlistat COMPOSITIONS
GB201223148D0 (en)	2013-02-06	Compositions
GB201222702D0 (en)	2013-01-30	Compositions
GB201218959D0 (en)	2012-12-05	Compositions
GB201209187D0 (en)	2012-07-04	Compositions